drugset

drugset / Trial / NCT00196820

Mono Efficacy of Capecitabine (MoniCa)

NCT00196820 ↗

Phase 2 Completed 200 enrolled GBG Forschungs GmbH Hoffmann-La Roche · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study done in patients with metastatic breast cancer in order to determine the efficacy of capecitabine

Timeline

Start: 2005-07
Primary completion: —
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capecitabine	Small molecule	2000 mg/m2	Oral

Indications